🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10100+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10100 recruiting trials

RecruitingNCT07487272

Single-cell and Spatial Transcriptomic Profiling of Gingival Tissues in Aggressive and Chronic Periodontitis: Deciphering Cellular Heterogeneity and Inflammatory Microenvironment Features

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07350850

A Multicenter Two-Cohort Study of Methotrexate, Rituximab, Sintilimab and Pirtobrutinib for Treatment-Naive PCNSL vs. Real-World Investigator-Selected Treatment (Observational Cohort)

🏥 Tongji Hospital📍 3 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07359053

MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma

🏥 Shanghai 6th People's Hospital📍 1 site📅 Started Dec 2025View details ↗
Phase 3RecruitingNCT07464912

A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

🏥 Beijing Tide Pharmaceutical Co., Ltd📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT06955169

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

👨‍⚕️ Erik P Sulman, MD,PhD, Duke University📍 9 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT06995508

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

👨‍⚕️ Anurag K Singh, Roswell Park Cancer Institute📍 1 site📅 Started Dec 2025View details ↗
Phase 1RecruitingNCT07138196

A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease

🏥 Qurient Co., Ltd.📍 8 sites📅 Started Dec 2025View details ↗
RecruitingNCT07247279

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

🏥 AstraZeneca📍 3 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07220603

An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)

🏥 PepGen Inc📍 3 sites📅 Started Dec 2025View details ↗
Phase 1RecruitingNCT07295067

Extracellular Vesicles for the Treatment of Syringomyelia

🏥 Xuanwu Hospital, Beijing📍 1 site📅 Started Dec 2025View details ↗
Phase 1RecruitingNCT07148050

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

👨‍⚕️ Colleen Annesley, MD, Seattle Children's Hospital📍 1 site📅 Started Dec 2025View details ↗
RecruitingNCT07243782

Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07304739

Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases

👨‍⚕️ Maobin Meng, Tianjin Medical University Cancer Institute and Hospital📍 3 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07265947

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

👨‍⚕️ Erik T. Goluboff, MD, MBA, Tyra Biosciences, Inc📍 2 sites📅 Started Dec 2025View details ↗
EARLY_Phase 1RecruitingNCT07313618

Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1)

👨‍⚕️ Fang Lu, Department of Ophthalmology, West China Hospital, Sichuan University📍 1 site📅 Started Dec 2025View details ↗
Phase 3RecruitingNCT07234695

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

🏥 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau📍 5 sites📅 Started Dec 2025View details ↗
NARecruitingNCT07307560

High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients

🏥 Zhejiang University📍 3 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07334912

AEF0217 in Participants With Down Syndrome

👨‍⚕️ Pier Vincenzo PIAZZA, MD, PhD, Aelis Farma📍 10 sites📅 Started Dec 2025View details ↗
RecruitingNCT07280104

Infants With Primary Congenital Hypothyroidism and Development

🏥 Nigde Omer Halisdemir University📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07187778

Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)

👨‍⚕️ Eric Jonasch, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Dec 2025View details ↗
← PreviousPage 31 of 505Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →